{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T13:53:51Z","timestamp":1724075631174},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/inf.0b013e31817bf9a9","type":"journal-article","created":{"date-parts":[[2008,10,24]],"date-time":"2008-10-24T07:09:28Z","timestamp":1224832168000},"page":"955-957","source":"Crossref","is-referenced-by-count":6,"title":["Amoxicillin for Postexposure Inhalational Anthrax in Pediatrics"],"prefix":"10.1097","volume":"27","author":[{"given":"John J.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles K.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary D.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210202","first-page":"1014","article-title":"Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-1-20210202","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalation anthrax.","volume":"167","author":"Friedlander","year":"1993","journal-title":"J Infect Dis"},{"key":"R3-1-20210202","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management.","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"R4-1-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R5-1-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/514622","article-title":"Pharmacodynamics of \u03b2-lactams.","volume":"27","author":"Turnidge","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R7-1-20210202","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00006454-199202000-00001","article-title":"Effectiveness of continuous vs. intermittent amoxicillin to prevent episodes of otitis media.","volume":"11","author":"Berman","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"R8-1-20210202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinids\/22.1.143","article-title":"Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children.","volume":"22","author":"Brook","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R9-1-20210202","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00006454-199204000-00004","article-title":"Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent otitis media: results of a randomized clinical trial.","volume":"11","author":"Casselbrant","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"R10-1-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5876(00)00465-1","article-title":"Comparison of amoxicillin and azithromycin in the prevention of recurrent otitis media.","volume":"58","author":"De Diego","year":"2001","journal-title":"Int J Ped Otorhinolaryng"},{"key":"R11-1-20210202","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1128\/AAC.40.12.2732","article-title":"Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children.","volume":"40","author":"Marchisio","year":"1996","journal-title":"Antimicrob Agents Chemo"},{"key":"R12-1-20210202","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00006454-199612000-00004","article-title":"Efficacy of antimicrobial prophylaxis for recurrent middle ear effusion.","volume":"15","author":"Mandel","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R13-1-20210202","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/archpedi.1989.02150240036013","article-title":"Prophylaxis of recurrent acute otitis media and middle ear effusion. Comparison of amoxicillin with sulfamethoxazole and trimethoprim.","volume":"143","author":"Principi","year":"1989","journal-title":"Am J Dis Child"},{"key":"R14-1-20210202","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00006454-199704000-00008","article-title":"Continuous twice daily or once daily amoxicillin prophylaxis compared with placebo for children with recurrent acute otitis media.","volume":"16","author":"Roark","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R15-1-20210202","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/S0264-410X(00)00293-0","article-title":"Antimicrobial prophylaxis for infants at risk for recurrent acute otitis media.","volume":"19","author":"Teele","year":"2001","journal-title":"Vaccine"},{"key":"R16-1-20210202","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/AAC.20.5.630","article-title":"Chronic salmonella bacteriuria with intermittent bacteremia treated with low doses of amoxicillin or ampicillin.","volume":"20","author":"Bassily","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-1-20210202","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/132.6.698","article-title":"Treatment of chronic enteric fever with amoxicillin.","volume":"132","author":"Bassily","year":"1975","journal-title":"J Infect Dis"},{"key":"R18-1-20210202","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.239.22.2352","article-title":"Treatment of typhoid carriers with amoxicillin. Correlates of successful therapy.","volume":"239","author":"Nolan","year":"1978","journal-title":"JAMA"},{"key":"R19-1-20210202","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s100960050166","article-title":"Comparison of oral cefixime and intravenous cetriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.","volume":"17","author":"Oski","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R20-1-20210202","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1542\/peds.64.5.627","article-title":"Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children.","volume":"64","author":"Ginsburg","year":"1979","journal-title":"Pediatrics"},{"key":"R22-1-20210202","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/infdis\/166.5.1184","article-title":"Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in Rhesus monkeys.","volume":"166","author":"Kelly","year":"1992","journal-title":"J Infect Dis"},{"key":"R25-1-20210202","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-198800357-00007","article-title":"Comparative pharmacokinetics of sulbactam\/ampicillin and clavulanic acid\/amoxicillin in human volunteers.","volume":"35","author":"Hampel","year":"1988","journal-title":"Drugs"},{"key":"R27-1-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5414\/CPP39167","article-title":"Comparative bioavailability of 4 amoxicillin formulations in healthy volunteers after single dose administration.","volume":"39","author":"Oliveira","year":"2001","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-200811000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:35:35Z","timestamp":1684604135000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200811000-00001"}},"subtitle":["Rationale For Dosing Recommendations"],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31817bf9a9","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}